Dyskinesias Clinical Trials

33 clinical trials for Dyskinesias across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes — RECRUITING
• Connectomic Guided DBS for Parkinson's Disease — RECRUITING · NA
• Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia — RECRUITING · NA
• Reliability and Validity Study of the Turkish Version of the Parkinson's Disease Dyskinesia Scale (PDYS-26) — RECRUITING
• Registry and Natural History of Epilepsy-Dyskinesia Syndromes — RECRUITING
• Pilot Study on Caffeine Efficiency in ADCY5-related Dyskinesia — COMPLETED
• Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy — TERMINATED · PHASE2
• Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy — TERMINATED · PHASE2
• Effects of Music Beat on Motor Function in Individuals At Risk for Psychotic Onset and Schizophrenia Patients — COMPLETED · NA
• Open-Label Extension Study of ASTORIA — TERMINATED · PHASE2
• Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components — TERMINATED · PHASE2
• A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia — COMPLETED · PHASE2
• Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia — SUSPENDED · PHASE2
• Effects of Transcranial Direct Current Stimulation (tDCS) on Motor Function in Schizophrenia Patients and Individuals at Risk for Psychotic Onset — OTHER · NA
• Effect of the Visual Information Change in Functional Dystonia — TERMINATED · NA
• Effects of Rhythmic Auditory Stimulation on Movements in Individuals at Risk for Psychotic Onset and Schizophrenia Patients — OTHER · NA
• Comparison of Open Chain Kinetic Exercises and Forward Head Posture Correction in Type II Scapular Dyskinesia — COMPLETED · NA
• An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's Disease — SUSPENDED · PHASE4
• Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia — TERMINATED · PHASE1
• Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease — COMPLETED · PHASE2
• Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias — COMPLETED · PHASE2
• Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias — COMPLETED · PHASE2
• Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias — COMPLETED · PHASE2
• A Follow-up of the Influencing Factors of Dyskinesia in Patients With Parkinson's Disease — OTHER
• ACP-103 to Treat Parkinson's Disease — COMPLETED · PHASE2
• Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease — COMPLETED · PHASE2
• Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's — COMPLETED · PHASE3
• Levetiracetam Treatment of L-dopa Induced Dyskinesias — COMPLETED · PHASE2
• Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects — COMPLETED · PHASE3
• Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1) — COMPLETED
• Effects of Talampanel on Patients With Advanced Parkinson's Disease — COMPLETED · PHASE1
• Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics — COMPLETED · PHASE4
• Study of LY300164 for the Treatment of Parkinson's Disease — COMPLETED · PHASE2

Refine this search